• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Okamoto Wataru  岡本 渉

ORCIDConnect your ORCID iD *help
… Alternative Names

OKAMOTO Wataru  岡本 渉

Less
Researcher Number 30441075
Other IDs
Affiliation (Current) 2025: 広島大学, 病院(医), 教授
Affiliation (based on the past Project Information) *help 2013 – 2014: 独立行政法人国立がん研究センター, 早期・探索臨床研究センター, 医員
2012: 近畿大学, 医学部, 助教
Review Section/Research Field
Principal Investigator
Clinical oncology
Keywords
Principal Investigator
分子標的治療 / Resistance / MET / Gastric Cancer / 分子標的薬 / 胃癌 / MET遺伝子増幅
  • Research Projects

    (1 results)
  • Research Products

    (5 results)
  • Co-Researchers

    (5 People)
  •  Antitumor Action of the MET Tyrosine Kinase Inhibitor in Gastric Cancer Positive for MET AmplificationPrincipal Investigator

    • Principal Investigator
      OKAMOTO Wataru
    • Project Period (FY)
      2012 – 2014
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Clinical oncology
    • Research Institution
      National Cancer Center Japan
      Kinki University

All 2014 2013 2012

All Journal Article Presentation

  • [Journal Article] Targeting MET Amplification as a New Oncogenic Driver.2014

    • Author(s)
      Kawakami H, Okamoto I, Okamoto W, Tanizaki J, Nakagawa K, Nishio K.
    • Journal Title

      Cancers(Basel)

      Volume: 6(3) Issue: 3 Pages: 1540-52

    • DOI

      10.3390/cancers6031540

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-24240122, KAKENHI-PROJECT-24501359, KAKENHI-PROJECT-24501360
  • [Journal Article] MET amplification as a potential therapeutic target in gastric cancer.2013

    • Author(s)
      Kawakami H, Okamoto I, Arao T, Okamoto W, Matsumoto K, Taniguchi H, Kuwata K, Yamaguchi H, Nishio K, Nakagawa K, Yamada Y.
    • Journal Title

      Oncotarget

      Volume: 4(1) Pages: 9-17

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24501360
  • [Journal Article] Antitumor action of the MET tyrosine kinase inhibitor crizotinib (PF-02341066) in gastric cancer positive for MET amplification.2012

    • Author(s)
      Okamoto W, Okamoto I, Arao T, Kuwata K, Hatashita E, Yamaguchi H, Sakai K, Yanagihara K, Nishio K, Nakagawa K.
    • Journal Title

      Mol Cancer Ther

      Volume: 11(7) Pages: 1557-1564

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24501360
  • [Presentation] Antitumor action of the MET tyrosine kinase inhibitor crizotinib in gastric cancer positive for MET amplification2013

    • Author(s)
      Wataru Okamoto, Isamu Okamoto, Hisato Kawakami, Kazuyoshi Yanagihara, Kazuto Nishio, Kazuhiko Nakagawa
    • Organizer
      International Symposium of Korean Society of Gastrointestinal Cancer
    • Place of Presentation
      Seoul, Korea
    • Data Source
      KAKENHI-PROJECT-24501360
  • [Presentation] MET遺伝子増幅陽性胃癌に対するMETチロシンキナーゼ阻害剤クリゾチニブの抗腫瘍効果2012

    • Author(s)
      岡本渉、岡本勇、荒尾徳三、仁科慎一、上田眞也、川上尚人、柳原五吉、倉田宝保、西尾和人、中川和彦
    • Organizer
      第10回日本臨床腫瘍学会学術集会
    • Place of Presentation
      大阪府大阪市 大阪国際会議場
    • Data Source
      KAKENHI-PROJECT-24501360
  • 1.  NAKAGAWA Kazuhiko (40298964)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 4 results
  • 2.  NISHIO Kazuto (10208134)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 5 results
  • 3.  OKAMOTO Isamu (10411597)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 4 results
  • 4.  ARAO Tokuzo (20441074)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 3 results
  • 5.  KAWAKAMI Hisato
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 3 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi